We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-3.64%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$300B
AUM Growth
-$49.2B
Cap. Flow
-$29.5B
Cap. Flow %
-9.85%
Top 10 Hldgs %
13.34%
Holding
11,668
New
1,182
Increased
3,623
Reduced
5,175
Closed
1,160

Sector Composition

Rank Sector Weight
1 Technology 13.08%
2 Financials 7.19%
3 Healthcare 6.35%
4 Consumer Discretionary 5.55%
5 Industrials 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVFAW
9701
DELISTED
SVF Investment Corp. Warrant
SVFAW
$2K ﹤0.01%
3,411
-5,907
-63% -$4.34K
PACXU
9702
DELISTED
Pioneer Merger Corp. Unit
PACXU
$2K ﹤0.01%
191
-267
-58% -$2.65K
SPIR.WS
9703
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
$2K ﹤0.01%
+7,677
New +$2.36K
RXRAW
9704
DELISTED
RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
$2K ﹤0.01%
3,354
OSTRW
9705
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$2K ﹤0.01%
9,065
GGMC
9706
DELISTED
Glenfarne Merger Corp. Class A Common Stock
GGMC
$2K ﹤0.01%
232
-200
-46% -$1.94K
SIERU
9707
DELISTED
Sierra Lake Acquisition Corp. Unit
SIERU
$2K ﹤0.01%
249
LGV.WS
9708
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$2K ﹤0.01%
+5,575
New +$2.58K
STRY.WS
9709
DELISTED
Starry Group Holdings, Inc. Warrants, each whole warrant exercisable to purchase 1.2415 shares of Class A common stock at an exercise price of $11.50 per 1.2415 shares of Class A common stock
STRY.WS
$2K ﹤0.01%
+2,575
New +$2.08K
FCAX.WS
9710
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$2K ﹤0.01%
5,116
-700
-12% -$393
LOTZ
9711
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$2K ﹤0.01%
1,200
-1,535
-56% -$2.89K
VTIQ
9712
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$2K ﹤0.01%
183
-488
-73% -$4.77K
ESSCR
9713
DELISTED
East Stone Acquisition Corporation Right
ESSCR
$2K ﹤0.01%
6,736
-1,980
-23% -$834
SPGS.WS
9714
DELISTED
Simon Property Group Acquisition Holdings, Inc. Warrants, each exercisable for one Class A common stock at an exercise price of $11.50 per share
SPGS.WS
$2K ﹤0.01%
+3,775
New +$2.23K
CHAA.WS
9715
DELISTED
Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHAA.WS
$2K ﹤0.01%
7,428
+6,269
+541% +$2.64K
PHAS
9716
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$2K ﹤0.01%
1,582
-3,018
-66% -$4.89K
PRBM.WS
9717
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
$2K ﹤0.01%
+7,975
New +$2.61K
EDNCU
9718
DELISTED
Endurance Acquisition Corp. Unit
EDNCU
$2K ﹤0.01%
+200
New +$1.99K
BLSA
9719
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$2K ﹤0.01%
251
+151
+151% +$1.49K
BOAS.WS
9720
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$2K ﹤0.01%
+6,745
New +$2.6K
HIGA
9721
DELISTED
H.I.G. Acquisition Corp.
HIGA
$2K ﹤0.01%
+179
New +$1.76K
PMVC.WS
9722
DELISTED
PMV Consumer Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PMVC.WS
$2K ﹤0.01%
10,060
-9,100
-47% -$3.36K
SANBW
9723
DELISTED
Sanaby Health Acquisition Corp. I Warrant
SANBW
$2K ﹤0.01%
10,500
ASAQ.WS
9724
DELISTED
Atlantic Avenue Acquisition Corp Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ASAQ.WS
$2K ﹤0.01%
7,794
-600
-7% -$200
AMPE
9725
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$2K ﹤0.01%
17
-274
-94% -$40K

Similar funds

UBS Group's Q1 2022 Portfolio in Review

As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS Group opened a new position in Shell worth $66.6M.

  • UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
  • UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
  • UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
  • UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
  • UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
  • UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
  • UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.

Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.